MOESM1 of Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction
figureposted on 2016-01-20, 05:00 authored by Roseanne Raphael, Diana Purushotham, Courtney Gastonguay, Marla Chesnik, Wai-Meng Kwok, Hsiang-En Wu, Sanjiv Shah, Shama Mirza, Jennifer Strande
Additional file 1: Figure S1. Â Flow cytometry to assess platelet activation. Purified platelet samples were incubated with fluorescently labeled antibodies against CD62P and CD41 and subject to flow cytometry. Platelets positive for CD41Â +Â but negative for CD62P are non-activated. CD62P positive platelets are activated.